InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results and Provides Business Update Nov 10, 2021
InMed Pharmaceuticals Makes Noise With Patent Application & Acquisition: Cannabis Stock Investing Nov 9, 2021
InMed Pharmaceuticals Announces Commencement of Phase 2 Clinical Trial Investigating Cannabinol (CBN), a Rare… Sep 30, 2021
InMed Pharmaceuticals Reports Full Year Fiscal 2021 Financial Results and Provides Business Update Sep 24, 2021
InMed Pharmaceuticals Signs Definitive Agreement to Acquire BayMedica, a Leading Commercial Manufacturer of Rare… Sep 13, 2021